What is Lexicon Pharmaceuticals's R&D?

Lexicon Pharmaceuticals (LXRX) reported R&D of $12.76M in Q1 2026.

How has Lexicon Pharmaceuticals's R&D changed year-over-year?

Lexicon Pharmaceuticals's R&D decreased by 16.6% year-over-year, from $15.3M to $12.76M.

What is the long-term trend for Lexicon Pharmaceuticals's R&D?

Over 4 years (2021 to 2025), Lexicon Pharmaceuticals's R&D has grown at a 2.7% compound annual growth rate (CAGR), from $55.05M to $61.12M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Lexicon Pharmaceuticals LXRX R&D

R&D at other companies

Eli LillyLLY

$3.51B+28.4%

Merck & Co.MRK

$12.59B+248%

CytokineticsCYTK

$95.53M-2.8%

Zevra Therapeutics, Inc.ZVRA

$4.39M+34.8%

MannkindMNKD

$17.23M+56.3%

Eton Pharmaceuticals, Inc.ETON

$1.88M+61.5%

Segments

By segment

See full

Reportable Segment$11.39M-16.3%

Other financials

Income statement

See full

Revenue$21.1M+1,572%

Gross profit$21.0M+1,604%

Operating income-$996.0K+96.1%

Net income-$1.0M+95.9%

EPS (diluted)$0.00+100%

Balance sheet

See full

Cash & equivalents$67.1M+6.7%

Total debt$57.7M-45.7%

Total equity$202.9M+64.9%

Total assets$268.8M-9.7%

Cash flow

See full

Operating cash flow-$14.7M+66.4%

CapEx--100%

Free cash flow-$17.2M+21.5%

Valuation

See full

Market cap$986.12M+273%

Enterprise value$976.73M+219%

P/S14.2×+5.7×

Profitability

See full

Gross margin99.5%+1.5pp

Operating margin-34.8%-16.8pp

Net margin-37.5%-18.1pp

FCF margin-578.5%-283pp

Returns & leverage

See full

Return on equity-16%-7.2pp

Debt / equity0.3×-0.6×

Current ratio18.8×+16.6×

Where this comes from

Reported directly by Lexicon Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lexicon Pharmaceuticals's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lexicon Pharmaceuticals's R&D?: Lexicon Pharmaceuticals (LXRX) reported R&D of $12.76M in Q1 2026.
How has Lexicon Pharmaceuticals's R&D changed year-over-year?: Lexicon Pharmaceuticals's R&D decreased by 16.6% year-over-year, from $15.3M to $12.76M.
What is the long-term trend for Lexicon Pharmaceuticals's R&D?: Over 4 years (2021 to 2025), Lexicon Pharmaceuticals's R&D has grown at a 2.7% compound annual growth rate (CAGR), from $55.05M to $61.12M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.